BIG
LKFT

Brooklyn Investment Group’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Brooklyn Investment Group’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-74
Closed -$1.86K – 3356
2025
Q1 		$1.86K Buy
+74
New +$1.87K ﹤0.01% 2178

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Brooklyn Investment Group's LKFT Position: Q2 2025 in Review

Brooklyn Investment Group sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2025, closing a stake of 74 shares — an estimated $1.86K sold.

Brooklyn Investment Group first reported a position in LKFT in Q1 2025 and held it in 1 quarter. The position peaked at $1.86K in Q1 2025. 85 funds tracked by Wall St. Rank hold LKFT as of Q2 2025.

  • Brooklyn Investment Group reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2025 after selling out during the quarter.
  • Brooklyn Investment Group sold 74 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2025, an estimated $1.86K.
  • Brooklyn Investment Group first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2025 and held it in 1 quarter.
  • Brooklyn Investment Group's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.86K in Q1 2025.
  • 85 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2025.

Based on Brooklyn Investment Group's 13F filing for Q2 2025, filed 12 Aug 2025.